Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

733.29 +17.73 (+2.48%)
Official Closing Price Updated: 7:00 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,212,933
Open 725.70
Bid (Size) 730.00 (1)
Ask (Size) 735.20 (10)
Prev. Close 715.56
Today's Range 712.21 - 738.68
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.82%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential deal value above $1.3 billion. 
Via Benzinga
What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
Via The Motley Fool
Topics Economy Government
Exposures Interest Rates Political

Performance

YTD
-5.8%
-5.8%
1 Month
-3.2%
-3.2%
3 Month
-15.9%
-15.9%
6 Month
-6.7%
-6.7%
1 Year
-6.8%
-6.8%

More News

Read More
2 Stocks That Plummeted During President Trump's First 100 Days in Office, and Where They Could Be Headed
Via The Motley Fool
Topics Artificial Intelligence Fraud Government
Exposures Artificial Intelligence Legal Political
3 Market-Beating Stocks with Promising Prospects
Via StockStory
LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price Pressures
Via StockStory
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
Got $500? 1 Billionaire-Approved Vanguard Index Fund to Buy and Hold Forever
Via The Motley Fool
Topics ETFs Economy
Exposures Economy
Why Weight-Loss Developer Stocks Tumbled on Tuesday
Via The Motley Fool
Topics Government
Exposures Political
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
Via The Motley Fool
Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)
Via Chartmill
Topics Government World Trade
Exposures Political Tariff
Eli Lilly (LLY): Buy, Sell, or Hold Post Q1 Earnings?
Via StockStory
Topics Government Stocks
Exposures Political US Equities
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill
Ford’s Cologne Workers To Strike On Wednesday, Says Report: Retail Sentiment Sours
Via Stocktwits
Topics Government
Exposures Political
KindlyMD Stock Surges To All-Time High After Announcing Merger With Nakamoto To Launch Bitcoin Treasury Strategy
Via Stocktwits
Topics Government Regulatory Compliance
Exposures Legal Political Regulatory
Big News! U.S. and China Trade Deal Shakes Up Markets
Via The Motley Fool
Topics World Trade
Exposures Tariff
Merck, Pfizer, Eli Lilly Stocks Rebound As Trump Targets Drug Costs With New Executive Order
Via Stocktwits
Topics Government
Exposures Political
Top S&P500 movers in Monday's pre-market session
Via Chartmill
Wall Street Rips Higher As Tariff Truce Halts US–China Economic Escalation
Via Benzinga
Topics Economy World Trade
Exposures Interest Rates Tariff
Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims'
Via Benzinga
Billionaire Chase Coleman Has 68% of His $24.5 Billion Portfolio Invested in 10 Stocks. Here's the Best of the Bunch.
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial
Via Benzinga
3 Healthcare Stocks to Keep an Eye On
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Eli Lilly's Zepbound Outperforms Wegovy In New Obesity Trial, But Trump's Drug Pricing Plan Keeps Retail Traders Wary
Via Stocktwits
Topics Government
Exposures Political
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Via Benzinga
Topics Government
Exposures Political

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 733.29
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 05/15/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.